成都欧林生物科技股份有限公司高级管理人员减持股份计划公告

Core Viewpoint - The announcement details the share reduction plans of senior management personnel at Chengdu Olin Biological Technology Co., Ltd., specifically financial officer Tan Yong and secretary of the board Wu Wei, who plan to reduce their holdings for personal financial planning reasons [3][12]. Summary by Sections Senior Management Shareholding Overview - As of the announcement date, financial officer Tan Yong holds 571,440 shares, representing 0.14% of the total share capital, with 515,440 shares being tradable and 56,000 shares being restricted [2]. - Secretary of the board Wu Wei holds 778,400 shares, accounting for 0.19% of the total share capital, with 714,000 shares being tradable and 64,400 shares being restricted [2]. Details of the Reduction Plan - Tan Yong and Wu Wei plan to reduce their holdings by up to 128,860 shares and 178,500 shares, respectively, through centralized bidding within three months after the announcement [3][12]. - The number of shares to be reduced will be adjusted if any corporate actions such as dividends or stock splits occur during the reduction period [3]. - Both individuals are compliant with regulations regarding share reductions and do not fall under any prohibitive conditions [3][12]. Background of the Reducing Parties - The reducing parties do not have any concerted actions with other shareholders [4]. - Neither Tan Yong nor Wu Wei has reduced their holdings since the company went public [5]. Commitments and Regulations - Tan Yong and Wu Wei have made commitments regarding their shareholding, including not transferring shares within 12 months of the company's listing and adhering to specific conditions if the company has not achieved profitability [7][8]. - They are also bound by regulations that limit the amount of shares they can sell within certain time frames and under specific conditions [8][9].